Your browser doesn't support javascript.
loading
Recombinant soluble CD32 suppresses disease progression in experimental epidermolysis bullosa acquisita.
Iwata, Hiroaki; Pipi, Elena; Möckel, Nicole; Sondermann, Peter; Vorobyev, Artem; van Beek, Nina; Zillikens, Detlef; Ludwig, Ralf J.
Afiliação
  • Iwata H; Department of Dermatology, University of Lübeck, Lübeck, Germany.
  • Pipi E; Department of Dermatology, University of Lübeck, Lübeck, Germany.
  • Möckel N; Department of Dermatology, University of Lübeck, Lübeck, Germany.
  • Sondermann P; SuppreMol GmbH, Munich, Germany.
  • Vorobyev A; Department of Dermatology, University of Lübeck, Lübeck, Germany; Institute of Experimental Dermatology, University of Lübeck, Lübeck, Germany.
  • van Beek N; Department of Dermatology, University of Lübeck, Lübeck, Germany.
  • Zillikens D; Department of Dermatology, University of Lübeck, Lübeck, Germany; Institute of Experimental Dermatology, University of Lübeck, Lübeck, Germany.
  • Ludwig RJ; Department of Dermatology, University of Lübeck, Lübeck, Germany; Institute of Experimental Dermatology, University of Lübeck, Lübeck, Germany. Electronic address: Ralf.Ludwig@uksh.de.
J Invest Dermatol ; 135(3): 916-919, 2015 Mar.
Article em En | MEDLINE | ID: mdl-25330298
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Epidermólise Bolhosa Adquirida / Receptores de IgG / Progressão da Doença Limite: Animals / Humans Idioma: En Revista: J Invest Dermatol Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Alemanha
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Epidermólise Bolhosa Adquirida / Receptores de IgG / Progressão da Doença Limite: Animals / Humans Idioma: En Revista: J Invest Dermatol Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Alemanha